尿血管紧张素原、中性粒细胞明胶酶相关脂质运载蛋白水平在高血压肾病中的变化及临床意义

Abstract
Figure/Table
References (28)
Related Citation (4)

Download: PDF (568 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the changes and clinical significance of urinary angiotensinogen (UAGT) and neutrophil gelatinase-associated lipocalin (NGAL) levels in hypertensive nephropathy. Methods A total of 130 hypertensive patients admitted to Yixing People’s Hospital, Jiangsu Province from March 2018 to March 2021 were selected. According to whether they had hypertensive nephropathy, they were divided into simple hypertension group (74 cases) and hypertensive nephropathy group (56 cases). The clinical data, UAGT, and NGAL levels of the two groups were compared. Logistic regression model was used to analyze the influencing factors of hypertensive nephropathy, and the diagnostic value of UAGT and NGAL levels in hypertensive nephropathy was analyzed by receiver operating characteristic curve. Results Levels of urinary microalbumin, serum creatinine, UAGT, and NGAL in hypertensive nephropathy group were higher than those in simple hypertension group, the differences were statistically significant (P ＜ 0.05). Multivariate analysis showed that UAGT, NGAL, and urinary microalbumin were independent influencing factors of hypertensive nephropathy (P ＜ 0.05). UAGT and NGAL had certain diagnostic value for hypertensive nephropathy, and the area under the curve was 0.862 and 0.869, respectively (P ＜ 0.05). Conclusion UAGT and NGAL levels are abnormally elevated in hypertensive nephropathy patients, and both of them are independent influencing factors of hypertensive nephropathy. Detection of changes in UAGT and NGAL levels can be used as sensitive indicators for evaluation of hypertensive nephropathy.

Key words： Hypertensive nephropathy Urinary angiotensinogen Neutrophil gelatinase-associated lipocalin

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Jiao CUI Ying▲ CHU Hong JIANG Qian

Cite this article:

CHEN Jiao CUI Ying▲ CHU Hong JIANG Qian. Changes and clinical significance of urinary angiotensinogen and neutrophil gelatinase-associated lipocalin levels in hypertensive nephropathy#br#[J]. 中国医药导报, 2022, 19(12): 79-81,87.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2022/V19/I12/79

[1] 施颖颖，李冀军，宋岩，等.高血压肾病患者血清胎球蛋白A水平与血管钙化的关系[J].中国中西医结合肾病杂志，2018，19（5）：454-455.
[2] 喻倩，李寒，王世相.慢性肾脏病患者高血压的容量管理[J].中华医学杂志，2021，101（4）：239-242.
[3] 林萍，高莹莹，卞淑芬.伴有高血压的原发性IgA肾病患者临床与病理特点分析[J].中国实验诊断学，2020，24（11）：90-91.
[4] 胡立群，李红旗.2017年高血压领域的争鸣与共识[J].中国临床保健杂志，2018，21（1）：4-6.
[5] Carriazo S，Vanessa Perez-Gomez M，Ortiz A. Hypertensive nephropathy：a major roadblock hindering the advance of precision nephrology [J]. Clin Kidney J，2020，13（4）：504-509.
[6] Ohashi N，Aoki T，Matsuyama T，et al. The Urinary Angiotensinogen to Urinary Albumin Ratio Reflects Whether the Renin-angiotensin System in the Kidney Is Activated due to Filtration of Plasma Angiotensinogen through the Damaged Glomeruli or the Production of Angiotensinogen in the Proximal Tubules [J]. Intern Med，2020，59（3）：357-364.
[7] Park HC，Kim J，Cho A，et al. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease [J]. J Korean Med Sci，2020，35（22）：165-175.
[8] Sisman P，Gul OO，Dirican M，et al. Urinary Neutrophil Gelatinase-Associated Lipocalin （NGAL） as a Marker of Diabetic Nephropathy in Type 1 Diabetic Patients [J]. Clin Lab，2020，66（1）：105-122.
[9] Seibert FS，Sitz M，Passfall J，et al. Prognostic Value of Urinary Calprotectin，NGAL and KIM-1 in Chronic Kidney Disease [J]. Kidney Blood Press Res，2018，43（4）：1255-1262.
[10] 王彬，赵立武，董嘉良.血清β2-微球蛋白、RBP4及尿NGAL联合检测在诊断妊娠期高血压早期肾损害价值[J].中国计划生育学杂志，2018，26（8）：698-701.
[11] Edgar VL，Jeffrey SB，Allen RN.肾脏病与高血压最新诊断和治疗[M].北京：人民军医出版社，2012：105-107.
[12] 钟鸿斌，谢良地.中国高血压基层管理指南[M].北京：人民卫生出版社，2015：91-93.
[13] Karam S. Hypertensive nephropathy and cancer：Is it the hypertension，the nephropathy，or both?[J]. J Clin Hypertens（Greenwich），2019，21（6）：792-793.
[14] Kao TW，Huang CC，Chen JW. Optimal blood pressure for the prevention of hypertensive nephropathy in nondiabetic hypertensive patients in Taiwan [J]. J Clin Hypertens（Greenwich），2020，22（8）：1425-1433.
[15] 刘洋，于文娟，李秀珍，等.高龄原发性高血压患者合并慢性肾脏病的危险因素[J].中华老年多器官疾病杂志，2019，18（1）：7-11.
[16] 梁灼源，韦锋，欧阳楚君，等.血管紧张素原基因多态性与高尿酸血症易感性的关系分析[J].中国医药科学，2021，11（23）：195-198.
[17] Hung MH，Huang CC，Chung CM，et al. 24-h ambulatory blood pressure variability and hypertensive nephropathy in Han Chinese hypertensive patients [J]. J Clin Hypertens（Greenwich），2021，23（2）：281-288.
[18] 赵西芳，吴菁，李恒娜，等.老年原发性高血压合并慢性肾脏病的影响因素[J].公共卫生与预防医学，2019，30（6）：128-132.
[19] 刘卫华，洪富源，吴家斌，等.高血压肾病患者尿NGAL与微炎症的关系[J].国际泌尿系统杂志，2018，38（1）：129-132.
[20] Seibert FS，Sitz M，Passfall J，et al. Urinary calprotectin，NGAL，and KIM-1 in the differentiation of primarily inflammatory vs. non-inflammatory stable chronic kidney diseases [J]. Ren Fail，2021，43（1）：417-424.
[21] 张文，李燕玲，刘凯.厄贝沙坦对老年高血压肾病患者的临床研究[J].中国临床药理学杂志，2019，35（18）：2006-2009.
[22] 莫荣浩，李梅，麦洁俭，等.尿NGAL联合血清CysC预测肾损伤合并急性心力衰竭患者临床病情严重度的有效性[J].中国医药科学，2021，11（13）：203-205，225.
[23] 霍飞霞，朱国贞.联合检测尿KIM-1及NGAL在特发性膜性肾病中的应用[J].中国临床研究，2021，34（9）：1185-1189.
[24] Kim H，Park S，Jhee JH，et al. Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease：a prospective cohort study [J]. BMC Nephrol，2019，20（1）：104-111.
[25] 张雷，刘江萍，刘志强，等.血清中肾素，血管紧张素Ⅱ表达水平与高血压患者动态血压参数的关系[J].解放军预防医学杂志，2018，36（11）：33-35.
[26] 张源波，李海明，杨萌，等.利尿钠肽及肾素-血管紧张素-醛固酮系统对高血压的影响[J].中国循证心血管医学杂志，2017，9（11）：129-130.
[27] Tang Z，Wang Y，Tao L，et al. Correction to：The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy [J]. BMC Nephrol，2019，20（1）：50-59.
[28] 柴巨川.探讨NGAL血尿同测对高血压肾病辅助诊断的临床价值[J].中国实验诊断学，2018，22（6）：984-986.